Global Protein Labeling Market Hits $3.0 billion in 2025 with 10.2% CAGR

Global protein labelling market was valued at $3.0 billion in 2025 and is growing at a CAGR of 10.2% during the forecast period (2026-2035). The market growth is driven by soaring R&D in proteomics, personalized medicine, and drug discovery, fueled by advanced tech like fluorescent/biotin probes, mass spec, and biochips, though high reagent costs and a shortage of skilled professionals pose challenges. Key drivers include rising healthcare spending, increased cancer/chronic disease prevalence, and technological innovation (bioorthogonal/enzymatic methods), with North America leading and Asia-Pacific growing fastest, while companies like Thermo Fisher, Merck, and PerkinElmer dominate.

Browse the full report description of “Protein Labeling Market Size, Share & Trends Analysis By Product (Reagents & Kits, Labels / Tags & Probes, Kits, and Services), By Labeling Technique (In-Vitro Labeling, In-Vivo Labeling, Bioorthogonal Labeling, and Detection Modality), By Application (Immunological Techniques, Cell-Based Assays / Flow Cytometry / Live-Cell Imaging, Proteomics & Mass Spectrometry, Drug Discovery & ADME Studies / Biomarker Discovery, And Diagnostics & Clinical Assays), and By End User ( Pharmaceutical & Biotechnology companies, Academic & Research Institutes, Contract Research Organizations (CROs), Clinical & Diagnostic Laboratories / Hospitals, and Industrial), Forecast Period (2026-2035)” of https://www.omrglobal.com/industry-reports/protein-labeling-market

Moreover, as chronic diseases rise, consumers prioritize products that promote healthier lifestyles, highlighting the significance of protein labeling in influencing purchasing decisions and driving market growth.

Key Innovators Driving Protein Labeling Transformation

The key players in the protein labeling market include Hoffmann-La Roche AG, Merck KGaA, PerkinElmer Inc., Promega Corp., Thermo Fisher Scientific Inc., among others. These companies are driving innovation in digital health solutions such as telemedicine, electronic health records, remote patient monitoring, and AI-powered clinical tools, shaping the future of healthcare delivery globally.

• In September 2025, Illumina Protein Prep launched as a high-performance assay for next-generation sequencing (NGS) based proteomics, now available globally after an early-access program. This solution enhances large-scale genomics studies and aids in drug discovery and clinical research, particularly in cancer, cardiometabolic, and immunologic diseases. By leveraging SOMAmer technology, it measures 9,500 unique human protein targets, providing comprehensive insights into protein biology essential for biomarker discovery and precision therapy development.
• In June 2025, Meala FoodTech and DSM-Firmenich collaborated to launch Vertis PB Pea, a clean-label pea protein designed to replace modified binders in plant-based meat alternatives. This functional ingredient allows for the creation of shorter, more recognizable ingredient labels, catering to the rising demand for plant-based foods. Already commercialized in Europe, the product will expand globally with DSM-Firmenich providing distribution and investment support. Vertis PB Pea boasts features such as being allergen-free, thermostable, and capable of enhancing texture and protein content in products like burgers and sausages. Its functionality is protected by two patents.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product
  • By Labeling Technique
  • By Application
  • By End User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape -
• Hoffmann-La Roche AG, Merck KGaA, PerkinElmer Inc., Promega Corp., Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Protein Labeling Market Report Segment

By Product

• Reagents & Kits
• Labels / Tags & Probes
• Kits
• Services

By Labeling Technique

• In-vitro labeling
• In-vivo labeling
• Bioorthogonal labeling
• Detection modality

By Application

• Immunological techniques
• Cell-based assays / Flow cytometry / Live-cell imaging.
• Proteomics & Mass spectrometry
• Drug discovery & ADME studies / Biomarker discovery.
• Diagnostics & Clinical assays

By Labeling Technique

• Pharmaceutical & Biotechnology companies
• Academic & Research Institutes.
• Contract Research Organizations (CROs).
• Clinical & Diagnostic Laboratories / Hospitals.
• Industrial

Global Protein Labeling Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/protein-labeling-market